Liquid biopsies and tumor mutational burden: the cutoff conundrum

被引：2
|
作者：
Kasi, Pashtoon Murtaza [1 ]
机构：
[1] Weill Cornell Med, Meyer Canc Ctr, Englander Inst Precis Med, New York, NY 10021 USA
来源：
NATURE MEDICINE | 2022年 / 28卷 / 09期
关键词：
D O I：
10.1038/s41591-022-01999-6
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Assessment of tumor mutational burden through a simple blood test could help to identify which patients are most likely to benefit from immunotherapy, but optimal cutoffs are not well established.
引用
收藏
页码：1753 / 1754
页数：2
相关论文
共 50 条
  • [41] Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors
    Sha, Dan
    Jin, Zhaohui
    Budczies, Jan
    Kluck, Klaus
    Stenzinger, Albrecht
    Sinicrope, Frank A.
    CANCER DISCOVERY, 2020, 10 (12) : 1808 - 1825
  • [42] Landscape of Tumor Mutational Burden in Indian NSCLC Patients
    Mehta, P.
    Dhabhar, B.
    Bhatt, A.
    Dattatreya, P.
    Maru, A.
    Vijayakumar, R.
    Maniar, V.
    Basade, M.
    Patel, K.
    Alurkar, S.
    Bahl, C.
    Todur, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S462 - S463
  • [43] Tumor mutational burden and efficacy of chemotherapy in lung cancer
    Song, Juan
    Yan, Yu
    Chen, Cuicui
    Li, Jiamin
    Ding, Ning
    Xu, Nuo
    Bao, Hairong
    Zhang, Xin
    Hong, Qunying
    Zhou, Jian
    Shao, Yang W.
    Song, Yuanlin
    Tong, Lin
    Hu, Jie
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (01): : 173 - 184
  • [44] The emerging development of tumor mutational burden in patients with NSCLC
    Zhang, Yu
    Wang, Lifeng
    Li, Rutian
    Liu, Baorui
    FUTURE ONCOLOGY, 2020, 16 (09) : 469 - 481
  • [45] Tumor mutational burden is not predictive of cytotoxic chemotherapy response
    Nikanjam, Mina
    Riviere, Paul
    Goodman, Aaron
    Barkauskas, Donald A.
    Frampton, Garrett
    Kurzrock, Razelle
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [46] Exploring associations between tumor mutational burden and tumor response in gynecologic malignancies
    Valente, Ana
    Essel, Kathleen Gong
    Ding, Kai
    Moore, Kathleen N.
    GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : E35 - E35
  • [47] A model based adjustment for tumor mutational burden across different tumor types
    Wang, M. H.
    Shi, W. W.
    Zhang, P.
    Zhao, S. H.
    Cao, J. Y.
    Chen, M. W.
    Shou, T.
    Hu, J.
    Tang, X. F.
    Song, T. Q.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Tumor mutational burden is associated with poor outcomes in diffuse glioma
    Wang, Lihong
    Ge, Jia
    Lan, Yang
    Shi, Yu
    Luo, Ying
    Tan, Yuhuan
    Liang, Mei
    Deng, Song
    Zhang, Xia
    Wang, Wenying
    Tan, Yaoyao
    Xu, Yuanyuan
    Luo, Tao
    BMC CANCER, 2020, 20 (01)
  • [49] Multiomics analysis of tumor mutational burden across cancer types
    Li, Lin
    Bai, Long
    Lin, Huan
    Dong, Lin
    Zhang, Rumeng
    Cheng, Xiao
    Liu, Zexian
    Ouyang, Yi
    Ding, Keshuo
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 5637 - 5646
  • [50] Tumor mutational burden and prognosis across pan-cancers
    Ding, H.
    Zhao, J.
    Zhang, Y.
    Wang, G.
    Cai, S.
    Qiu, F.
    ANNALS OF ONCOLOGY, 2018, 29
12345